Provided by Tiger Trade Technology Pte. Ltd.

Ensysce Biosciences Inc.

0.5275
-0.0195-3.56%
Post-market: 0.53050.0030+0.57%16:30 EDT
Volume:339.22K
Turnover:177.57K
Market Cap:1.92M
PE:-0.09
High:0.5623
Open:0.5361
Low:0.4805
Close:0.5470
52wk High:4.85
52wk Low:0.3144
Shares:3.63M
Float Shares:3.12M
Volume Ratio:1.10
T/O Rate:10.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0968
EPS(LYR):-11.4482
ROE:-294.39%
ROA:-109.79%
PB:1.59
PE(LYR):-0.05

Loading ...

Feb 01, 2023

Major Issues Report

8-K - Current report
Jan 31, 2023

Major Issues Report

8-K - Current report
Jan 19, 2023

Major Issues Report

8-K - Current report
Jan 13, 2023

Correspondence

CORRESP [Cover] - Correspondence
Jan 13, 2023

Major Issues Report

8-K - Current report
Dec 27, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 16, 2022

Major Issues Report

8-K - Current report
Dec 16, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 08, 2022

Major Issues Report

8-K - Current report
Dec 06, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 06, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 05, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Dec 01, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 18, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 17, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 16, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 14, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Oct 27, 2022

Major Issues Report

8-K - Current report